303: A new obesity startup, an acquisition gone wrong, & the future of Teledoc
The Readout Loud
00:00
Innovative Obesity Drug Development Strategies
This chapter delves into the emergence of obesity drugs Wagovi and Zepbound, the launch of obesity-focused startup MetCera, and the development and potential of GLP-1 receptor agonists in combating obesity. It discusses the importance of addressing cardiometabolic issues, pharmaceutical company strategies in developing obesity drugs, and potential future directions in obesity treatment.
Transcript
Play full episode
